Essex Woodlands Fund IX-GP, L.P. (CIK 0001652285)

Latest company ownership

Shares held
3,490,921
Last filed at
Sep 6, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q1 2025Q4
VERO - Venus Concept Inc.
Role: 10% Owner
Shares held
1,598,722
Last filed at
Jan 19, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 1, 2023 Sep 6, 2023 EyePoint Pharmaceuticals, Inc. 10% Owner Sell 32.5 -20,000 -0.57% ✗ $198K
Sep 1, 2023 Sep 6, 2023 EyePoint Pharmaceuticals, Inc. 10% Owner Sell 32.5 -20,000 -0.57% ✗ $198K
Aug 30, 2023 Sep 1, 2023 EyePoint Pharmaceuticals, Inc. 10% Owner Sell 17.5 -139,471 -3.82% ✗ $1.5M
Aug 28, 2023 Aug 30, 2023 EyePoint Pharmaceuticals, Inc. 10% Owner Sell 17.5 -148,712 -3.91% ✗ $1.7M
Aug 24, 2023 Aug 30, 2023 EyePoint Pharmaceuticals, Inc. 10% Owner Sell 17.5 -223,936 -5.57% ✗ $2.5M
Aug 24, 2023 Aug 28, 2023 EyePoint Pharmaceuticals, Inc. 10% Owner Sell 17.5 -223,936 -5.57% ✗ $3M
Aug 22, 2023 Aug 24, 2023 EyePoint Pharmaceuticals, Inc. 10% Owner Sell 17.5 -167,881 -4.01% ✗ $2.3M
Dec 15, 2021 Dec 17, 2021 Venus Concept Inc. 10% Owner Buy 100.0 +3,920,000 13.94% ✗ $4.9M
Jun 25, 2018 Jul 3, 2018 EyePoint Pharmaceuticals, Inc. 10% Owner Buy 100.0 +16,864,066 49.49% ✗ $21.3M
Mar 28, 2018 Apr 2, 2018 EyePoint Pharmaceuticals, Inc. 10% Owner Buy 100.0 +8,606,324 100.00% ✗ $9.5M